Acetylation of SERCA2a, Another Target for Heart Failure Treatment?

Circ Res. 2019 Apr 26;124(9):1285-1287. doi: 10.1161/CIRCRESAHA.119.315017.

Authors

Xiongwen Chen¹, Xiaoying Zhang¹, Scott Gross², Steven R Houser¹, Jonathan Soboloff²

Affiliations

¹ From the Cardiovascular Research Center (X.C., X.Z., S.R.H.), Temple University School of Medicine, Philadelphia, PA.
² the Fels Institute for Cancer Research and Molecular Biology (S.G., J.S.), Temple University School of Medicine, Philadelphia, PA.

No abstract available

Keywords: Editorials; acetylation; action potential; heart failure; sarcoplasmic reticulum.

Publication types

Editorial
Research Support, N.I.H., Extramural
Comment

MeSH terms

Acetylation
Heart Failure*
Humans
Sarcoplasmic Reticulum
Sarcoplasmic Reticulum Calcium-Transporting ATPases*
Sirtuin 1

Substances

SIRT1 protein, human
Sirtuin 1
Sarcoplasmic Reticulum Calcium-Transporting ATPases

Grants and funding